A Role for Α-Synuclein in Axon Growth and Its Implications in Corticostriatal Glutamatergic Plasticity in Parkinson’s Disease

Molecular Neurodegeneration - United Kingdom
doi 10.1186/s13024-020-00370-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Α-Synuclein: A Therapeutic Target for Parkinson’s Disease?

Pharmacological Research
Pharmacology
2008English

The Role of Lipids Interacting With Α-Synuclein in the Pathogenesis of Parkinson’s Disease

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2017English

Α-Synuclein and Anti-Α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls

PLoS ONE
Multidisciplinary
2012English

Elevated Serum Α-Synuclein Autoantibodies in Patients With Parkinson’s Disease Relative to Alzheimer’s Disease and Controls

Frontiers in Neurology
Neurology
2017English

Parkinson’s Disease: Assay of Phosphorylated Α-Synuclein in Skin Biopsy for Early Diagnosis and Association With Melanoma

Brain Sciences
Neuroscience
2016English

The Cell-Death-Associated Polymer PAR Feeds Forward Α-Synuclein Toxicity in Parkinson’s Disease

Molecular Cell
Cell BiologyMolecular Biology
2019English

Selective Α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson’s Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2018English

Exosomal DNA Aptamer Targeting Α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson’s Disease Model

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on Α-Synuclein

Neuron
Neuroscience
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy